Drug intelligence / Profile preview

Actioval

Development stage: Unknown
Lead developer: Laboratorio Arama
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Actioval is a probiotic nutritional supplement developed and marketed by Laboratorio Arama, a Chilean subsidiary of OPKO Health. It is formulated to support gastrointestinal health by restoring and maintaining a healthy balance of intestinal microbiota. As a probiotic product, it typically contains live microorganisms such as *Lactobacillus acidophilus* and *Bifidobacterium lactis*, which contribute to improved digestive function and may assist in the prevention or management of dysbiosis and diarrhea. The product is positioned within the consumer health and nutraceutical market in Chile and is not classified as a prescription pharmaceutical drug.

Brand names: Actioval
Other names: probiotics

Beyond the preview

Go deeper on Actioval.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actioval.

Explore the full profile